Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 21 Oct 2016
At a glance
- Drugs Dapagliflozin (Primary) ; Digoxin; Warfarin
- Indications Atrial fibrillation; Atrial flutter; Heart failure; Thrombosis; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 28 Oct 2009 Actual end date changed from Sep 2009 to Aug 2009 as reported by ClinicalTrials.gov.
- 23 Sep 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 23 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.